Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI SOLAIRIA-1 and SOLAIRIA-2 will evaluate GB-0895 in approximately 1,600 patients with severe…CISION PRNewswireDecember 1, 2025
EP YAYING Marks Three Years in the U.S., Weaving Cultural Connection Through Eastern Elegance NEW YORK, Dec. 1, 2025 /PRNewswire/ — This month, EP YAYING, the acclaimed…CISION PRNewswireDecember 1, 2025
MaxsMaking Inc. Addresses SEC Trading Suspension and Affirms Full Cooperation with Regulators SHANGHAI, Dec. 1, 2025 /PRNewswire/ — MaxsMaking Inc. (Nasdaq: MAMK) ("MaxsMaking" or…CISION PRNewswireDecember 1, 2025
CN Energy Group. Inc. Announces Launch of PATHENBOT Robotics Solutions Platform and PATHENBOT's Official Website LISHUI, China, Dec. 1, 2025 /PRNewswire/ — CN Energy Group. Inc. ("CNEY" or…CISION PRNewswireDecember 1, 2025
Lee's Pharm Supports Disaster Relief Efforts for Wang Fuk Court in Tai Po HONG KONG, Dec. 1, 2025 /PRNewswire/ — Lee’s Pharmaceutical Holdings Limited ("Lee’s Pharm"…CISION PRNewswireDecember 1, 2025
Press ReleaseGEEKOM Unveils GeekBook X14 Pro: The World's First All-Metal Ultralight Laptop TAIPEI, Dec. 1, 2025 /PRNewswire/ — GEEKOM has officially announced the upcoming launch…CISION PRNewswireDecember 1, 2025
Press ReleaseKuCoin Launches KuCoin Alpha: Enriching the Ecosystem with Seamless On-Chain Innovation PROVIDENCIALES, Turks and Caicos Islands, Dec. 1, 2025 /PRNewswire/ — KuCoin, a…CISION PRNewswireDecember 1, 2025
XPENG Announces Vehicle Delivery Results for November 2025 36,728 vehicles delivered in November, up 19% YoY GUANGZHOU, China, Dec. 1, 2025…CISION PRNewswireDecember 1, 2025